Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.
Dunford, James E; Kwaasi, Aaron A; Rogers, Michael J; Barnett, Bobby L; Ebetino, Frank H; Russell, R Graham G; Oppermann, Udo; Kavanagh, Kathryn L.
J Med Chem
; 51(7): 2187-95, 2008 Apr 10.
Artigo em Inglês | MEDLINE | ID: mdl-18327899
Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.
Human farnesyl pyrophosphate synthase inhibition by nitrogen bisphosphonates: a 3D-QSAR study.
Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site 'capping' phenyls.
Synthesis and biological evaluation of a series of aromatic bisphosphonates.
1-(Fluoroalkylidene)-1,1-bisphosphonic acids are potent and selective inhibitors of the enzymatic activity of Toxoplasma gondii farnesyl pyrophosphate synthase.
Structural characterization of substrate and inhibitor binding to farnesyl pyrophosphate synthase from Pseudomonas aeruginosa.
Fluorescent Farnesyl Diphosphate Analogue: A Probe To Validate trans-Prenyltransferase Inhibitors.
Allosteric non-bisphosphonate FPPS inhibitors identified by fragment-based discovery.
New insights into human farnesyl pyrophosphate synthase inhibition by second-generation bisphosphonate drugs.
Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.